Literature DB >> 8727596

Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease.

S Tracy1, N M Chapman, J Romero, A I Ramsingh.   

Abstract

Coxsackieviruses B (CVBs) are etiological agents of human inflammatory myocardial disease. The genetics of the coxsackieviral virulence phenotype in mice are now beginning to be understood with the availability of infectious cDNA copies of CVB genomes. Investigations to date with CVB3 and CVB4 have shown that sites within a non-translated region and in the capsid proteins can affect the virulence phenotype. The relative importance of these sites to expression of the phenotype remains unclear.

Entities:  

Mesh:

Year:  1996        PMID: 8727596     DOI: 10.1016/0966-842x(96)10026-3

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  11 in total

1.  Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein.

Authors:  A I Ramsingh; W T Lee; D N Collins; L E Armstrong
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Nitric oxide inhibition of coxsackievirus replication in vitro.

Authors:  C Zaragoza; C J Ocampo; M Saura; A McMillan; C J Lowenstein
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 3.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.

Authors:  M K Slifka; R Pagarigan; I Mena; R Feuer; J L Whitton
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge.

Authors:  Jeonghyun Ahn; Eun Seok Jun; Hui Sun Lee; Seung Yong Yoon; DongHou Kim; Chul-Hyun Joo; Yoo Kyum Kim; Heuiran Lee
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway.

Authors:  Zhiheng Chen; Li Yang; Yong Liu; Anliu Tang; Xin Li; Juan Zhang; Zuocheng Yang
Journal:  Mol Cell Biochem       Date:  2013-09-27       Impact factor: 3.396

7.  Meta-analysis of the association of enteroviruses with human heart disease.

Authors:  C Baboonian; T Treasure
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

8.  Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death.

Authors:  Sun-Mi Kim; Jung-Hyun Park; Sun-Ku Chung; Joo-Young Kim; Ha-Young Hwang; Kwang-Chul Chung; Inho Jo; Sang-Ick Park; Jae-Hwan Nam
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon.

Authors:  M S Horwitz; T Krahl; C Fine; J Lee; N Sarvetnick
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin.

Authors:  D Fairweather; C M Lawson; A J Chapman; C M Brown; T W Booth; J M Papadimitriou; G R Shellam
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.